SOURCE: UV Flu Technologies, Inc.

UV Flu Technologies, Inc.

December 15, 2009 09:00 ET

UV Flu Technologies Appoints Senior Executive to Board

CENTERVILLE, MA--(Marketwire - December 15, 2009) - UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce the appointment of Mr. John J. Lennon as President, Chief Executive Officer, Chief Financial Officer and Secretary of the Company.

Over the past 22 years Mr. Lennon has served in a variety of senior executive positions including as President, Chief Executive Officer, Chief Financial Officer and Secretary, Treasurer for a number of corporate entities. Since 2007 he has consulted and advised to several technology and resource sector firms and during this period he also served as a Director for a number of those companies. Since 2004 he has been President of Chamberlain Capital Partners which assists companies in the area of maximizing shareholder value through increased sales, cost reduction and refined business strategy.

Mr. Lennon continues to assist companies in obtaining debt financing, private placements or other methods of funding. He is responsible for corporate reporting, press releases, and funding-related initiatives. From 1987 to 2004, Mr. Lennon served as Senior Vice President of Janney Montgomery Scott, Osterville, MA, Smith Barney and Prudential Bache Securities, managing financial assets for high net worth individuals.

Further details regarding the appointment are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.


UV Flu Technologies, Inc.
John J. Lennon, President & CEO

Contact Information

  • Investor Information:
    Boundary Point Investor Relations, Inc.
    Toll-Free: 1-888-355-8838
    Email Contact